BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7113899)

  • 21. Detrimental arrhythmogenic and sustained beneficial hemodynamic effects of oral salbutamol in patients with chronic congestive heart failure.
    Mettauer B; Rouleau JL; Burgess JH
    Am Heart J; 1985 Apr; 109(4):840-7. PubMed ID: 3984838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and hemodynamic experience with enalapril in congestive heart failure.
    Cody RJ
    Am J Cardiol; 1985 Jan; 55(2):36A-40A. PubMed ID: 2981464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variability of hemodynamic responses to acute digitalization in chronic cardiac failure due to cardiomyopathy and coronary artery disease.
    Cohn K; Selzer A; Kersh ES; Karpman LS; Goldschlager N
    Am J Cardiol; 1975 Apr; 35(4):461-8. PubMed ID: 1119395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of captopril in heart failure complicating acute myocardial infarction and persistence of acute haemodynamic effects in chronic heart failure after 3 years of treatment.
    Mattioli G; Ricci S; Rigo R; Fusaro MT; Cappello C
    Postgrad Med J; 1986; 62 Suppl 1():164-6. PubMed ID: 3534855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemodynamic and myocardial performance characteristics after verapamil use in congestive heart failure.
    Ferlinz J; Citron PD
    Am J Cardiol; 1983 May; 51(8):1339-45. PubMed ID: 6846161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemodynamic effects of dibutyryl cyclic AMP in congestive heart failure.
    Matsui S; Murakami E; Takekoshi N; Emoto J; Matoba M
    Am J Cardiol; 1983 May; 51(8):1364-8. PubMed ID: 6303101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sustained beneficial hemodynamic responses to large doses of transdermal nitroglycerin in congestive heart failure and comparison with intravenous nitroglycerin.
    Rajfer SI; Demma FJ; Goldberg LI
    Am J Cardiol; 1984 Jul; 54(1):120-5. PubMed ID: 6430054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemodynamic effects of inhaled terbutaline in congestive heart failure patients without lung disease: beneficial cardiotonic and vasodilator beta-agonist properties evaluated by ventricular catheterization and radionuclide angiography.
    Slutsky R
    Am Heart J; 1981 May; 101(5):556-60. PubMed ID: 7223595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiocirculatory effects of afterload reduction with oral trimazosin in severe chronic congestive heart failure.
    Awan NA; Hermanovich J; Whitcomb C; Skinner P; Mason DT
    Am J Cardiol; 1979 Jul; 44(1):126-31. PubMed ID: 453037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy.
    Faxon DP; Halperin JL; Creager MA; Gavras H; Schick EC; Ryan TJ
    Am Heart J; 1981 May; 101(5):548-56. PubMed ID: 7013458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemodynamic effects of intravenous bepridil in patients with normal left ventricular function.
    Alpert JS; Benotti JR; Brady PM; McCue JE; Weiner BH; Ockene IS
    Am J Cardiol; 1985 Mar; 55(7):20C-24C. PubMed ID: 3872053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of intravenous atrial natriuretic factor with furosemide in patients with heart failure.
    Connelly TP; Francis GS; Williams KJ; Beltran AM; Cohn JN
    Am Heart J; 1994 Feb; 127(2):392-9. PubMed ID: 8296708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute hemodynamic effect of oral nifedipine in severe chronic congestive heart failure.
    Elkayam U; Weber L; Torkan B; Berman D; Rahimtoola SH
    Am J Cardiol; 1983 Nov; 52(8):1041-5. PubMed ID: 6637820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemodynamic effects of prolonged intravenous therapy with enoximone in patients with severe congestive heart failure.
    Ferry DR; Kennedy GT; O'Rourke RA; Crawford MH
    J Cardiovasc Pharmacol; 1988 Jan; 11(1):115-22. PubMed ID: 2450249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute haemodynamic effects of felodipine in congestive heart failure.
    Emanuelsson H; Hjalmarson A; Holmberg S; Waagstein F
    Eur J Clin Pharmacol; 1985; 28(5):489-93. PubMed ID: 3899668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of low-dose flosequinan on left ventricular systolic and diastolic chamber performance.
    Starling MR
    Am Heart J; 1994 Jul; 128(1):124-33. PubMed ID: 8017265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemodynamic effects of prostaglandin E1 infusion in patients with acute myocardial infarction and left ventricular failure.
    Popat KD; Pitt B
    Am Heart J; 1982 Apr; 103(4 Pt 1):485-9. PubMed ID: 7199815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemodynamic and hormonal effects of high-dose transdermal nitroglycerin in patients with chronic congestive heart failure.
    Elkayam U; Roth A; Henriquez B; Weber L; Tonnemacher D; Rahimtoola SH
    Am J Cardiol; 1985 Sep; 56(8):555-9. PubMed ID: 3929585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sustained effectiveness of chronic prazosin therapy in severe chronic congestive heart failure.
    Bertel O; Burkart F; Bühler FR
    Am Heart J; 1981 May; 101(5):529-33. PubMed ID: 7223592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.